Factors associated with treatment modification during the first year of contemporary HAART

Podobne knjige/članki

• Naïve patients receiving TDF/FTC-EFV as 2 pills are more likely to modify regimen components than patients receiving a TDF/FTC/EFV single pill
  od: Perez-Valero, I, et al.
  Izdano: (2010)
• Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
  od: Vasudevan, Janani, et al.
  Izdano: (2012)
• Contemporary Costs of HIV Health Care in the HAART Era
  od: Gebo, Kelly A., et al.
  Izdano: (2010)
• Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort
  od: van Lunzen, J, et al.
  Izdano: (2010)
• Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatment
  od: Perez-Molina, JA, et al.
  Izdano: (2010)